This inventor holds 1 USPTO granted patent. Top assignee: Kainos Medicine Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Boksuk Kim: Innovator in Alpha-Synuclein Modulation
Introduction
Boksuk Kim is a notable inventor based in Cheongju, South Korea. He has made significant contributions to the field of medical research, particularly in the modulation of alpha-synuclein, a protein associated with neurodegenerative diseases.
Latest Patents
Boksuk Kim holds a patent for "Modulators of Alpha-Synuclein." This innovation is crucial in the ongoing research aimed at understanding and potentially treating conditions such as Parkinson's disease.
Career Highlights
Currently, Boksuk Kim is affiliated with Kainos Medicine Inc., where he continues to advance his research and development efforts. His work is pivotal in the quest for effective therapies targeting neurodegenerative disorders.
Collaborations
Boksuk Kim collaborates with talented colleagues, including Yeontae Chung and Jae Moon Lee. Together, they contribute to the innovative environment at Kainos Medicine Inc.
Conclusion
Boksuk Kim's work in the modulation of alpha-synuclein represents a significant step forward in medical research. His contributions are vital for the future of treatments for neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile